The effect of hyaluronic acid injection in eliminating adhesions in hysteroscopy of patients with Asherman's syndrome

Investigating the effect of hyaluronic acid injection in eliminating adhesions in hysteroscopy of patients withAsherman's syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N42

Enrollment

Registered

2024-06-08

Start date

2024-07-22

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine adhesions. Intrauterine synechiae

Interventions

Intervention 1: Intervention group: The patients undergo hysteroscopy. At the end of the hysteroscopy, 3 cc of hyaluronic acid gel is injected into the uterine cavity using the IUI catheter. Then the

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women with Asherman syndrome Patient consent to participate in the study

Exclusion criteria

Exclusion criteria: Contraindications for the use of hyaluronic acid Presence of pelvic infections Menopause Pregnancy History of cervical cancer Severe coagulative disorders Presence of underlying diseases such as thrombophilia, cardiovascular and respiratory disorders.

Design outcomes

Primary

Measure	Time frame
Intrauterine adhesions. Timepoint: Once, two months after the intervention. Method of measurement: Sonohysterography.	—

Secondary

Measure	Time frame
Endometrial thickness. Timepoint: Once, two months after the intervention. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fdavaritanha@sina.tums.ac.ir+98 21 8831 3955

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026